SEI Trust Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$81.3M Sell
763,384
-44,578
-6% -$4.37M 0.79% 12
2014
Q2
$67M Sell
807,962
-711,103
-47% -$55.4M 0.65% 21
2014
Q1
$108M Sell
1,519,065
-595,650
-28% -$46.7M 1.07% 7
2013
Q4
$159M Buy
2,114,715
+370,726
+21% +$25.8M 1.51% 3
2013
Q3
$110M Buy
1,743,989
+78,441
+5% +$4.69M 1.2% 4
2013
Q2
$85.3M Buy
+1,665,548
New +$86.8M 1.04% 8

Other funds holding GILD

SEI Trust Company's GILD Position: Q3 2014 in Review

SEI Trust Company reduced its Gilead Sciences (GILD) stake by 5.5% in Q3 2014, selling an estimated $4.37M and leaving 763,384 shares worth $81.3M. The position accounts for 0.79% of the portfolio, ranked #12.

SEI Trust Company first reported a position in GILD in Q2 2013 and has held it in 6 quarters since. The position peaked at $159M in Q4 2013. 1,327 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • SEI Trust Company held 763,384 shares of Gilead Sciences worth $81.3M as of Q3 2014.
  • SEI Trust Company sold 44,578 Gilead Sciences shares in Q3 2014, an estimated $4.37M.
  • Gilead Sciences made up 0.79% of SEI Trust Company's portfolio in Q3 2014, its #12 holding.
  • SEI Trust Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 6 quarters since.
  • SEI Trust Company's Gilead Sciences position peaked at $159M in Q4 2013.
  • 1,327 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.